ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Distribution Services

Medipal Holdings Corp.

Business Summary

Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. Its operations are carried out through the following segments: Prescription Pharmaceutical Wholesale Business; Cosmetics, Daily Necessities, and Over-The-Counter (OTC) Pharmaceutical Wholesale Business; and Animal Health Products Wholesale Business. The Prescription Pharmaceutical Wholesale Business segment conducts wholesale business for hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and OTC Pharmaceutical Wholesale Business segment deals with wholesale business for drugstores, home centers, convenience stores, and supermarkets. The Animal Health Products Wholesale Business segment handles wholesale business for animal hospitals, farms, agricultural cooperatives, and processed food manufacturers. The company was founded on October 8, 1898 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2022 JPYUSD
Revenue3,290.92B29,285.77M
Gross Profit205,112M1,825.28M
Operating income45,625M406.01M
Income before tax57,284M509.76M
Net income29,424M261.84M
EBITDA59,963M533.60M
Diluted EPS131.401.16
Dividends Per Share440.39
Total Assets1,709.47B14,084.23M
Total liabilities1,060.38B8,736.41M
Total equity530,305M4,369.14M
Operating cash flow61,216M544.75M
Currency in JPYCurrency in USD

Historical Data

 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 3,146.34B 3,181.93B 3,253.12B 3,211.17B 3,290.92B
Gross Profit 214,843M 220,621M 224,246M 201,486M 205,112M
Operating income 44,261M 49,469M 53,111M 38,578M 45,625M
Income before tax 63,466M 63,461M 75,536M 49,237M 57,284M
Net income 34,780M 34,359M 37,969M 23,927M 29,424M
EBITDA 59,635M 63,397M 67,798M 53,370M 59,963M
Diluted EPS 149.90 145.15 165.33 106.79 131.40
Dividends Per Share 34 38 41 42 44
Total Assets 1,618.81B 1,617.91B 1,644.27B 1,679.93B 1,709.47B
Total liabilities 1,046.16B 1,025.06B 1,036.85B 1,040.99B 1,060.38B
Total equity 484,668M 496,880M 500,319M 523,014M 530,305M
Operating cash flow 63,558M 63,716M 56,917M 34,448M 61,216M
 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 28,388.27M 28,693.30M 29,920.43M 30,277.68M 29,285.77M
Gross Profit 1,938.44M 1,989.46M 2,062.49M 1,899.78M 1,825.28M
Operating income 399.35M 446.08M 488.48M 363.74M 406.01M
Income before tax 572.63M 572.26M 694.73M 464.24M 509.76M
Net income 313.80M 309.83M 349.21M 225.60M 261.84M
EBITDA 538.06M 571.68M 623.56M 503.21M 533.60M
Diluted EPS 1.35 1.30 1.52 1.00 1.16
Dividends Per Share 0.30 0.34 0.37 0.39 0.39
Total Assets 15,221.61M 14,617.25M 15,231.15M 15,203.02M 14,084.23M
Total liabilities 9,836.95M 9,261.05M 9,604.47M 9,420.78M 8,736.41M
Total equity 4,557.29M 4,489.13M 4,634.51M 4,733.15M 4,369.14M
Operating cash flow 573.46M 574.56M 523.49M 324.80M 544.75M

Valuation Measures

Mar 2022
PER14.37
ROA1.73%
ROE5.58%
Operating margin1.38%
Profit margin0.89%

Key executives

  • President & Representative Director: Shuichi Watanabe
  • Senior Manager-Compliance: Takeshi Yanagida
  • Director, VP & Head-Pharmaceutical Business: Yasuhiro Choufuku
  • Executive Officer: Hisashi Tsutsui
  • Executive Officer & Deputy GM-Administration: Nobuhito Yanai

Shareholders

  • Medipal Holdings Corp. (14.1%)
  • Silchester International Investors LLP (8.1%)
  • Nomura Asset Management Co., Ltd. (3.0%)
  • Mp Group Mediceo Employee Stock Ownership Plan (2.4%)
  • Kobayashi Pharmaceutical Co., Ltd. (2.0%)
  • Eisai Pension Fund (1.7%)
  • The Vanguard Group, Inc. (1.5%)
  • Daiichi Sankyo Pension Fund (1.3%)
  • Sumitomo Pharma Co., Ltd. (1.3%)
  • Daiwa Asset Management Co. Ltd. (1.2%)

Contact Details

Related Companies

  • Medipal Insurance Service Co., Ltd.
  • MVC Co., Ltd.
  • SPLine Corp.
  • Tokimo Co., Ltd.
  • M.I.C. (Medical Information College), Inc.
  • class A Network Co., Ltd.
  • EVERLTH ODS Co., Ltd.
  • Sinopharm Group Beijing Huahong Co., Ltd.
  • Medi-Skette Corp.
  • MEDIE Co., Ltd.
  • OrphanPacific, Inc.
  • Kuraya (USA) Corp.
  • MP Agro Co., Ltd.
  • MM Corp.
  • Everlth Agrotech KK
  • Kuraya Kasei KK
  • Evals Ods Co. Ltd.
  • Yamahiro Kuraya Sanseido, Inc.
  • Alfarm KK
  • Butsuryu 24, Inc.
  • Maruzen Yakuhin KK
  • Atoru Naha Yakuhin KK
  • ASTEC Co., Ltd.
  • Medipal Foods Corp.
  • Maruzen Yakuhin Corp.
  • Yakuju Corp.
  • Senshu Yakuhin Co. Ltd.
  • Shikoku Yakugyo Co., Ltd.
  • Heisei Yakuhin Co. Ltd.
  • Paltac Corporation

Competitors

    Last Updated on 10 Aug, 2022

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more